Adaptive Biotechnologies Corporation develops immune medicine platforms for various diseases, including COVID-19. Their immunoSEQ and clonoSEQ products are used for research and diagnosis of specific diseases. The company collaborates with Genentech and Microsoft to develop therapies and diagnostic tests.